Skip to main content
Clinical Trials/CTRI/2017/10/010031
CTRI/2017/10/010031
Recruiting
Phase 1

Role of lymphadenectomy in patients undergoing interval debulking surgery for Carcinoma Ovary

IRB CMCH Vellore0 sites120 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: null- CA OVARY
Sponsor
IRB CMCH Vellore
Enrollment
120
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
IRB CMCH Vellore

Eligibility Criteria

Inclusion Criteria

  • Patients who have undergone neoadjuvant chemotherapy for primary ovarian cancer or PPC followed by optimal interval debulking

Exclusion Criteria

  • Sub\-optimal debulking, poor performance status

Outcomes

Primary Outcomes

Not specified

Similar Trials